Umuthi 'Ksarelto "imiyalelo ukusetshenziswa njengendlela laphawula, kuyinto anticoagulant yesenzo oqondile. Ngo ngesisekelo lesi izidakamizwa kuyinto okusithiyayo ngqo of isici Xa. Ngaphezu kwalokho, lokhu izidakamizwa has a selectivity kuqhathaniswa eliphezulu. Kepha pharmacokinetics yayo, it is ngokushesha kakhulu amuncwa umzimba, ukufinyelela lokuhlushwa esiphezulu egazini emva ezimbili kuphela amahora amane emva ekuphathweni ngomlomo. Uma sikhuluma izici excretion okusezingeni eliphezulu zomuthi, kanye umchamo kanye endleni ukuboniswa mayelana 92-95% imithi "Ksarelto". Yokusetshenziswa (intengo, ngasendleleni, lokhu kuchaza ruble 1500) ebhalwe la ukuthi ingxenye esele awuphumi ngefomu angashintshiwe ngu excretion kwezinso.
Iyatholakala lokhu anticoagulant ngesimo amaphilisi round pink amnyama noma umbala iba nsundu ngokubomvu, eliqukethe e ngezithako zawo eziyishumi, nanhlanu noma amabili angu ka rivaroxaban micronized. Nezinsizasenzo kukhona izinto ezifana croscarmellose sodium, sodium lauryl sulfate, hypromellose 5cP, microcrystalline cellulose, magnesium stearate futhi monohydrate-lactose. Ukwakheka igobolondo kuhlanganisa ama-titanium dioxide, Macrogol 3350 futhi yaba bomvu oxide ferric. Ngaphezu kwalokho, umthamo ezincane siqukethe hypromellose 5cP.
Khomba iphilisi "Ksarelto" yokusetshenziswa ngokuvamile Kunconywa ezigulini eziye ngaphambilini zabhekana izinqubo kuhlinzwa emachosheni aphansi. Ngenxa yalesi sigaba sabantu isenzo anticoagulant njengesinyathelo ngempumelelo yokuvimbela ukuthuthukiswa ikusasa thromboembolism emithambo yegazi. Ngaphezu kwalokho, lesi sidakamizwa "Ksarelto" ngokuphelele efanelekayo nokuvimbela yokuphindela DVT futhi PE. Futhi, leli thuluzi kufanele sisetshenziselwe nokuvimbela unhlangothi abantu fibrillation atrial, uhlobo non-valvular. Ukuvimbela ukuthuthukiswa thromboembolism letindzala kanye nokwelashwa deep vein thrombosis futhi occlusion ngokujulile Umthambo yamaphaphu futhi incoma amaphilisi "Ksarelto" imfundo manual.
Sebenzisa le anticoagulant akuvunyelwe contraindicated kubantu nge emathunjini, intracranial noma yimuphi omunye izinhlobo ukopha, ifomu okunzima nokwehluleka ukusebenza kwezinso noma ukungabekezelelani ukuze galactose. Uma kwenzeka hypersensitivity lesiguli rivaroxaban noma ukusabela iguliswa nezinye excipients ezisohlwini Ukwakheka, futhi akufanele bathathe lesi sidakamizwa "Ksarelto". Yokusetshenziswa unqabela ambeke kakhulu futhi ngesikhathi sokukhulelwa. Izimo nazo ne-lactose, impatho nabanye anticoagulants, isifo sesibindi, ephelezelwa coagulopathy, nemibandela kuhlobene nengozi eliphezulu nokopha. Ngaphezu kwalokho, awukwazi ukuthatha abesifazane imithi, nabancelisayo, futhi abantu abangazange sebethole engu-nesishiyagalombili.